Skip to content

West Pharmaceutical Services WST Proprietary Products — Interest Expense

Discontinued — last reported Q4 '19

Similar metrics at other companies

Eli Lilly logo
LLYReportable Segment — Interest Expense
$332M+36.1%
Starwood Property Trust logo
STWDProperty Segment — Interest Expense
$27.95M+211%
Starwood Property Trust logo
STWDOperating Segments — Interest Expense
$70.2M+56.0%
Elevance Health logo
ELVReportable Segments — Interest Expense
$357M+3.8%
Dick's Sporting Goods logo
DKSReportable Segment — Interest Expense
$16.12M+19.2%
RB Global logo
RBAReportable Segment — Interest Expense
$44M-11.8%

Other financials

Income statement

See full
Revenue$844.9M+21.1%
Gross profit$296.4M+27.8%
Operating income$177.1M+65.5%
Net income$138.8M+54.6%
EPS (diluted)$1.92+56.1%

Balance sheet

See full
Cash & equivalents$521.4M+29.0%
Total debt$321.0M+4.4%
Total equity$3.0B+11.5%
Total assets$4.1B+13.6%

Cash flow

See full
Operating cash flow$89.9M-30.5%
CapEx$42.7M-40.1%
Free cash flow$47.2M-18.8%

Valuation

See full
Market cap$22.86B+11.6%
Enterprise value$22.66B+11.1%
P/E42.1×-1.7×
P/S7.1×0.0×

Profitability

See full
Gross margin36.3%+1.7pp
Operating margin20.3%+1.2pp
Net margin16.8%+0.7pp

Returns & leverage

See full
Return on equity19.1%+1.7pp
Debt / equity0.1×0.0×
Current ratio2.7×-0.1×

Where this comes from

Reported directly by West Pharmaceutical Services in its filing.

Tagged under the XBRL concept us-gaap:InterestExpense.

The official record: West Pharmaceutical Services’s 10-K, filed February 24, 2020, on SEC EDGAR. View the filing →

Questions, answered.

What does proprietary products — interest expense mean?
The interest costs associated with debt allocated to this business segment.
How do you interpret proprietary products — interest expense?
Increasing interest expense relative to segment profit may indicate rising leverage or higher borrowing costs.
How does proprietary products — interest expense compare across companies?
Often reported as 'Allocated Interest Expense' in segment reporting for companies with centralized treasury functions.